TY  - GEN
AU  - Hájková,R
AU  - Indrová,M
AU  - Jandlová,T
AU  - Bubeník,J
AU  - Reinis,M
TI  - Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors
SN  - 0015-5500
PY  - 2000///0424
KW  - Animals
KW  - CD4-Positive T-Lymphocytes
KW  - immunology
KW  - Cancer Vaccines
KW  - therapeutic use
KW  - Carcinoma
KW  - Combined Modality Therapy
KW  - Cross Reactions
KW  - Cytotoxicity Tests, Immunologic
KW  - DNA, Complementary
KW  - genetics
KW  - Disease Progression
KW  - Genetic Therapy
KW  - Immunotherapy, Active
KW  - Interleukin-2
KW  - Killer Cells, Natural
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Neoplasm Recurrence, Local
KW  - prevention & control
KW  - Neoplasm Transplantation
KW  - Neoplasm, Residual
KW  - Recombinant Fusion Proteins
KW  - physiology
KW  - Sarcoma, Experimental
KW  - metabolism
KW  - Spleen
KW  - T-Lymphocytes, Cytotoxic
KW  - Transfection
KW  - Tumor Cells, Cultured
KW  - Vaccination
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ER  -